Overall, all patients in the FOS + IMI arm had negative BC at 3 daysCure rates: IMI + FOS 4 (50%) VAN 3 (43%) In-hospital mortality: IMI + FOS 3 (37.5%),VAN 1 (14.2%) Persistent bacteriemia: IMI + FOS 0, VAN 1 (14.2%)Relapse: IMI + FOS 0, VAN 1 (14.2%). The gene discussed is FOS; the disease is breast cancer.